Resonance Health contracted for two new clinical trials
Filed with ASX · · 1 page · English
Earlier from Resonance Health
- TGA, CE Mark clearance for A.I. Solution FerriSmart
- Alliance Partner Agreement with Blackford Analysis
- Additional Info. in relation to 4 May 2018 announcement
- Resonance Deal to distribute Diabetic Retinopathy AI tool
- Appointment of CEO
Later from Resonance Health
- Additional Information on Announcement Dated 23 August 2018
- Change of Substantial Shareholder Notification
- Pause in Trading
- New Work Order to provide services for Clinical Trial
- Change of Director's Interest Notice
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health